Glucotrack Inc (GCTK) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GCTK Annual Cash Flow →
The data below summarizes Glucotrack Inc's cash flow activity from Jun 30 2025 to Jun 30 2026, enabling a period-by-period view of cash movement.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-8.15
Depreciation & amortization0.04
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.12
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-0.27
Linkage Difference On Principal Of Loans From Stockholders-
Increase Decrease In Operating Lease Rightofuse Assets-
Equity Issuance Costs-
Issuance Of Restricted Shares As Compensation To Board Of Directors-
Gain Loss Related To Litigation Settlement-
Gain Loss On Equity Issuance-
Amortization Of Original Issue Discount Related To Promissory Note0.15
Derivative Gain Loss On Derivative Net0.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.20
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.10
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.88
Discontinued operations0.00
Net Cash flow from Operating Activities-7.66
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase In Longterm Restricted Cash-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.01
Financing Activities
Short-term debt Net0.00
Other borrowing transactions1.69
Long-term debt - borrowings-0.30
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock Net Of Issuance Costs-
Proceeds Allocated To Series C Preferred Stock Net Of Cash Issuance Expenses-
Proceeds Allocated To Series C Warrants Net Of Cash Issuance Expenses-
Proceeds Received From Underwritten Public Offering-
Net Proceeds Received From Underwritten Public Offering-
Proceeds From Issuance Of Convertible Promissory Note-
Proceeds From Issuance Of Convertible Promissory Note One-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.39
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-7.66
Total Cash Flow-6.26
4 historic quarters locked

Sign in to unlock the full Glucotrack Inc cash flow history.

About Glucotrack Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-038317

Figures are derived from filed reports and may be restated. Historical data is subject to revision.